Table 1 Clinical and environmental data in cervical HPV-associated lesion and cancer.

From: A prognostic value of CD45RA+, CD45RO+, CCL20+ and CCR6+ expressing cells as ‘immunoscore’ to predict cervical cancer induced by HPV

 

Control (n = 14)

CIN

CC** (n = 15)

CIN I** (n = 17)

CIN II (n = 16)

CIN III (n = 19)

Age years (mean ± SD)*

31.9 ± 5.3a

33.1 ± 10.4b

31.90 ± 7.3c

32.2 ± 8.2d

47.9 ± 8.9

Ethinicity n (%)**

White

7 (50.0)

7 (41.2)

10 (62.5)

8 (47.1)

5 (33.3)

Afro-Brazilian

7 (50.0)

10 (58.8)

6 (37.5)

11 (52.9)

10 (66.7)

Alcohol consumption n (%)**

Yes

4 (28.5)

7 (41.2)

6 (37.5)

9 (47.4)

5 (33.3)

No

10 (71.5)

10 (58.8)

10 (62.5)

10 (52.6)

10 (66.7)

Tobacoo use n (%)**

Yes

4 (28.5)

10 (58.8)

3 (18.7)e

2 (10.5)f

5 (33.3)

No

10 (71.5)

7 (41.2)

13 (81.3)

17 (89.5)

10 (66.7)

Age at first sexual intercourse (average ± SD)*

18.4 ± 2.4

18.1 ± 3.2

16.9 ± 2.7

16.7 ± 2.7

17.2 ± 1.3

Number of partners (average ± SD)*

4.0 ± 2.9

3.4 ± 1.7

6.7 ± 8.6

5.7 ± 4.7

4.0 ± 1.2

Number of abortions (average ± SD)*

1 ± 0.9

0.7 ± 0.9

0.3 ± 0.8

0.3 ± 0.4

0.7 ± 0.8

Positive HPV DNA n (%)

0 (0)

15 (88.2)

14 (87.5)

18 (94.7)

15 (100)

  1. *One way Anova test and Dunn's multiple comparison post test; **χ2 test.
  2. **CIN cervical intraepithelia neoplasia, CC cervical cancer.
  3. ap < 0.01 control versus CC, bp < 0.01 CIN I versus CC; cp < 0.01 CIN II versus CC; dp < 0.001, CIN III versus CC; ep < 0.01 CIN II versus CIN I; fp < 0.001 CIN III versus CIN I.